Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry

Statistics in Medicine

Volumn 30, Issue 6, 2011, Pages 654-665

  Lau, Bryan ^a   Cole, Stephen R ^b   Gange, Stephen J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b IL   (United States)

Author keywords

Cause specific hazards; Competing risks; Hazard ratio; Mixture model; Subdistribution; Subdistribution hazards; Survival analysis

Indexed keywords

ARTICLE; CALCULATION; HAZARD RATIO; INTERMETHOD COMPARISON; PARAMETRIC MIXTURE MODEL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DATA INTERPRETATION, STATISTICAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79951697665     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4123     Document Type: Article

References (43)

1. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Statistics in Medicine 2007; 26:2389-2430. DOI: 10.1002/sim.2712.
2. Lau B, Cole SR, Gange SJ. Competing risk regression methods for epidemiologic data. American Journal of Epidemiology 2009; 170:244-256. DOI: 10.1093/aje/kwp107.
3. Prentice RL, Kalbleisch JD, Peterson Jr AV, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978; 34:541-554.
4. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, NY, 1980; 247-277.
5. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association 1999; 94:496-509.
6. Beyersmann J, Dettenkofer M, Bertz H, Schumacher M. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards. Statistics in Medicine 2007; 26:5360-5369. DOI: 10.1002/sim.3006.
7. Beyersmann J, Schumacher M. Letter to the editor: misspecificed regression model for the subdistribution hazard of a competing risks. Statistics in Medicine 2007; 26:1649-1652. DOI: 10.1002/sim.2727.
8. Cox DR. The analysis of exponentially distributed lifetimes with 2 types of failure. Journal of the Royal Statistical Society Series B-Statistical Methodology 1959; 21:411-421.
9. Larson MG, Dinse GE. A mixture model for the regression analysis of competing risks data. Applied Statistics 1985; 34:201-211.
10. Maller RA, Zhou X. Analysis of parametric models for competing risks. Statistica Sinica 2002; 12:725-750.
11. Hernán M. The hazards of hazard ratios. Epidemiology 2010; 21:13-15. DOI: 10.1097/EDE.0b013e3181c1ea43.
12. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data (2nd edn). Springer: New York, NY, 2003.
13. Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics 2005; 61:223-229. DOI: 10.1111/j.0006-341X.2005.031209.x.
14. Andersen PK, Abildstrom SZ, Rosthøj S. Competing risks as a multi-state model. Statistical Methods in Medical Research 2002; 11:203-215. DOI: 10.1191/0962280202sm281ra.
15. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of Statistics 1988; 16:1141-1154.
16. Beyersmannn J, Latouche A, Buchholz A, Schumacher M. Simulating competing risks data in survival analysis. Statistics in Medicine 2009; 28:956-971. DOI: 10.1002/sim.3516.
17. Grambauer N, Schumacher M, Beyersmann J. Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified. Statistics in Medicine 2010; 29:875-884. DOI: 10.1002/sim.3786.
18. Latouche A, Boisson V, Chevret S, Porcher R. Misspecified regression model for the subdistribution hazard of a competing risk. Statistics in Medicine 2007; 26:965-974. DOI: 10.1002/sim.2600.
19. Geskus RB. Cause-specific cumulative incidence estimation and the Fine and Gray model under both left truncation and right censoring. Biometrics 2010. DOI: 10.1111/j.1541-0420.2010.01420.x.
20. Cox C, Chu H, Schneider MF, Muñoz A. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Statistics in Medicine 2007; 26:4352-4374. DOI: 10.1002/sim.2836.
21. Cox C. The generalized F distribution: an umbrella for parametric survival analysis. Statistics in Medicine 2008; 27:4301-4312. DOI: 10.1002/sim.3292.
22. Bates DM, Watts DG. Nonlinear Regression Analysis and its Applications. Wiley: New York, NY, 1998.
23. Efron B. The Jacknife, the Bootstrap, and Other Resampling Plans. Society for Industrial and Applied Mathematics: Philadelphia, PA, 1982.
24. Efron B, Tibshirani R. An Introduction to the Bootstrap. Chapman & Hall: London, 1993.
25. Lagakos SW, Schoenfeld DA. Properties of propositional-hazards score tests under misspecified regression models. Biometrics 1984; 40:1037-1048.
26. Schemper M. Cox analysis of survival data with non-proportional hazard functions. The Statistician 1992; 41:455-465.
27. Kalbfleisch JD, Prentice RL. Estimation of the average hazard ratio. Biometrika 1981; 68:105-112.
28. Sasieni P. Maximum weighted partial likelihood estimators for the Cox model. Journal of the American Statistical Association 1993; 88:144-152.
29. Schemper M, Wakounig S, Heinze G. The estimation of average hazard ratios by weighted Cox regression. Statistics in Medicine 2009; 28:2473-2489. DOI: 10.1002/sim.3623.
30. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J. The women's interagency HIV study. WIHS Collaborative Study Group. Epidemiology 1998; 9:117-125.
31. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users. JAMA 1998; 280:544-546.
32. Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, Gallant JE. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001; 15:1707-1715.
33. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes 2001; 27:251-259.
34. Rodriguez-Arenas MA, Jarrin I, del Amo J, Iribarren JA, Moreno S, Viciana P, Peña A, Sirvent JL, Vidal F, Lacruz J, Gutierrez F, Oteo JA, Asencio R, Castilla J, Hoyos SP. CoRIS-MD. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in spain. AIDS Research and Human Retroviruses 2006; 22:715-723. DOI: 10.1089/aid.2006.22.715.
35. Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, Rickenbach M. the Swiss HIV Cohort Study. All cause mortality in the swiss HIV cohort study from 1990 to 2001 in comparison with the swiss population. AIDS 2004; 18:1835-1843.
36. 3. Journal of Acquired Immune Deficiency Syndromes 2007; 44:179-187. DOI: 10.1097/01.qai.0000247229.68246.c5.
37. Leemis LM, McQueston JT. Teacher's corner: univariate distribution relationships. The American Statistician 2008; 62:45-53. DOI: 10.1198/000313008X270448.
38. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Computer Methods and Programs in Biomedicine 2004; 75:45-49. DOI: 10.1016/j.cmpb.2003.10.004.
39. Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Statistics in Medicine 2005; 24:3089-3110. DOI: 10.1002/sim.2174.
40. Allignol A, Schumacher M, Beyersmann J. A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data. Biometrical Journal 2010; 52:126-137. DOI: 10.1002/bimj.200900039.
41. Lau B, Cole SR, Moore RD, Gange SJ. Evaluating competing adverse and beneficial outcomes using a mixture model. Statistics in Medicine 2008; 27:4313-4327. DOI: 10.1002/sim.3293.
42. Jeong JH, Fine J. Direct parametric inference for the cumulative incidence function. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2006; 55:187-200. DOI: 10.1111/j.1467-9876.2006.00532.x.
43. Jeong JH, Fine J. Parametric regression on cumulative incidence function. Biostatistics 2007; 8:184-196. DOI: 10.1093/biostatistics/kxj040.